Diptirani Rath

Dr. Diptirani Rath


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
DRDiptirani Rath
Diptirani Rath
DKDurga Madhab Kar
Durga Madhab Kar
SPSandeep Kumar Panigrahi
Sandeep Kumar Panigrahi
LMLaxmidhar Maharana
Laxmidhar Maharana

22 December 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
Subhasish SahooSubhasish Sahoo
Subhasish Sahoo
DRDiptirani Rath
Diptirani Rath
DKDurga Madhab Kar
Durga Madhab Kar
SPSovan Pattanaik
Sovan Pattanaik

6 June 2025 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
SPSandesh Kumar Pattanaik
Sandesh Kumar Pattanaik
PAPrajapati Manisha Anil
Prajapati Manisha Anil
SJSudipta Jena
Sudipta Jena
DRDiptirani Rath
Diptirani Rath

27 July 2017 in Natural Product Research
Verified
Journal Article
Open access
DRDiptirani Rath
Diptirani Rath
SPSandeep Kumar Panigrahi
Sandeep Kumar Panigrahi
DKDurga Madhab Kar
Durga Madhab Kar
LMLaxmidhar Maharana
Laxmidhar Maharana
The GC-MS analysis of fractions of methanol extract of stem of Cuscuta reflexa (Family Convolvulaceae) was carried out using a THERMO TRACE 1300 Gas Chromatograph equipped and coupled to a mass detector THERMO TSQ 8000 spectrometer with an TG 5MS (30 m × 0.25 mm, 0.25 μm) of capillary column. Database of National Institute of Standards and Technology (NIST) library was used to identify the components. GC-MS revealed two known compounds i.e. 2-Methoxy-4-vinyl phenol (6.80%) and Benzofuran-2,3-dihydro (20.89%) and other 12 unknown compounds such as 3,5-di-tert-Butyl-4-hydroxyanisole (35.50%); Hexatriacontane (12.02%); n-Hexadecanoic acid (10.12%); Scoparone (7.97%); Hexadecanoic acid methyl ester (5.22%); 1,3-Benzenediamine, N, N, N′, N′ tetramethyl- (15.43%); Phenol, 4(3-hydroxy1propenyl), 2-methoxy (9.31%); Phenol, 2,4 bis (1,1dimethylethyl); 2,3,5,6-Tetramethyl para phenylene diamine (14.18%); Retinoic acid-5,6-epoxy-5,6-dihydro (20.46%); 2,4-Dihydroxy-2,5-dimethyl-3(2H)furan-3-one (10.13%); 2,3-dihydro-3,5-dihydroxy-6-methyl-2-Propyl-tetrahydro-pyran-3-ol (10.13%); Pregn-4-ene-18-oic acid (5.75%) as some of the major compounds in its different fractions. Retinoic acid-5,6-epoxy-5,6-dihydro found as major compound may be responsible for blood glucose lowering potency.

1 February 2026 in Current Diabetes Reviews
Verified
Journal Article
Open access
PDF file
SPSandesh Kumar Pattanaik
Sandesh Kumar Pattanaik
MAManisha Prajapati Anil
Manisha Prajapati Anil
SJSudipta Jena
Sudipta Jena
DRDiptirani Rath
Diptirani Rath
Diabetes is a chronic, irreversible, non-infectious metabolic syndrome associated with low insulin production by the pancreas or due to insulin resistance. The management landscape for diabetes is swiftly evolving due to ongoing advancements. Conventional treatment approaches have struggled to fully address the root causes of the disease while also carrying significant risks of adverse effects. Flavonoids are an extensive class of phytonutrients present in grains, vegetables, fruits, cocoa, tea, wine, and nuts. Many studies have reported that flavonoids have shown diversified pharmacological activity in recent years. Thus, this review will give you an overview of the significant anti-diabetic potential of promising flavonoids. Various search engines such as PubMed, Scopus, Google Scholar, and WoS have been explored by using the keywords “apigenin,” “luteolin,” “naringenin,” “hesperidin,” “kaempferol,” “quercetin,” “myricetin” and “taxifolin” with “anti-diabetic.” The anti-diabetic activity of flavonoids is attributed to various mechanisms, including α glucosidase, α-amylase inhibitory effects, GLUT4 expression, antioxidant, and apoptosis. However, their inadequate biopharmaceutical qualities make their effectiveness in clinical translation constrained. This review aims to highlight plant-derived flavonoids through in-vitro, in vivo, and clinical insights. Additionally, the review highlights the recent advancement in the drug delivery system in diabetes to overcome the limitation of flavonoids.

8 October 2024 in Cellular and Molecular Biology
Verified
Journal Article
Open access
PDF file
Subhasish SahooSubhasish Sahoo
Subhasish Sahoo
HKHaseeb Khan
Haseeb Khan
DKDurga Madhab Kar
Durga Madhab Kar
SPSovan Pattanaik
Sovan Pattanaik
DRDiptirani Rath
Diptirani Rath
Fresh stem bark decoction of Litsea monopetala has been practiced for the treatment of jaundice and other liver disorders by the tribal communities of Thakht-e-Sulaiman hills from West Pakistan. As per the folkloric claim, this study aims to identify the phytoconstituents and evaluate the hepatoprotective action of stem bark methanol extract of L. monopetala (LMME). The in-vitro hepatoprotective effect of L. monopetala was performed by H2O2-induced toxicity in the HepG2 cell line and in-vivo by cclt;sub>4-induced hepatotoxicity in Wistar albino rats taking Silymarin as standard drug. Phytoconstituents were identified using LC-QTOF-MS analysis followed by in-silico docking and validation. Molecular docking interactions between identified compounds of L. monopetala and two target proteins, namely 1VJY and 5HYK were presented. In this study, treatment with LMME at 100 µg/mL showed 67.73 % cell viability as compared to H2O2 (100 µM) treated alone i.e., 18.55 % in the HepG2 cell line. In-vivo treatment of LMME reversed the altered serum biochemical parameters and reduced the inflammatory response similar to that of the Silymarin-treated group supported by histopathological investigation. This research reveals that L. monopetala is a rich source of flavonoids and phenols which supports its hepatoprotective effects and is proposed for its usage as a promising hepatoprotective agent after controlled trials